跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,101 条关于
“Immune thrombocytopenia”
全部
15,101
临床试验
7,055
药物
434
机构
85
资讯
7,527
去年
InnoCare's Orelabrutinib Shows Promise in Treating Primary Immune Thrombocytopenia
去年
Immune Thrombocytopenia Presents Diagnostic Challenges with Unpredictable Disease Course
去年
FDA Approves Doptelet for Pediatric Immune Thrombocytopenia with New Sprinkle Formulation
去年
Sanofi's Wayrilz Becomes First BTK Inhibitor Approved for Immune Thrombocytopenia Treatment
去年
FDA Grants Orphan Drug Designation to Novartis' Ianalumab for Primary Immune Thrombocytopenia
9个月前
Ouro Medicines' Gamgertamig Receives Second FDA Orphan Drug Designation for Immune Thrombocytopenia
9个月前
CASI Pharmaceuticals' CID-103 Shows 73% Response Rate in Phase 1 Immune Thrombocytopenia Trial
23天前
FDA Grants Type B Pre-IND Meeting for RTX-NP (MabionCD20) in Immune Thrombocytopenia
5个月前
Takeda's Anti-CD38 Therapy Mezagitamab Achieves 91% Response Rate in Immune Thrombocytopenia Phase II Trial
3个月前
INNOCARE's BTK Inhibitor Orelabrutinib Receives New Drug Application Acceptance in China for Primary Immune Thrombocytopenia Treatment
第 1 页,共 753 页
上一页
下一页